UFPT vs VCT.L
UFPT: A specialized contract manufacturer producing custom single-use and single-patient medical devices for major OEMs across minimally invasive surgery, wound care, orthopedics, and biopharma applications. VCT.L: A global leader in high-performance PEEK and PAEK polymer solutions for mission-critical industrial, medical, and aerospace applications.
Side-by-side fundamentals
| Metric | UFPT | VCT.L | Edge |
|---|---|---|---|
| Price as of 2026-08-05 close | $322.06 | £7.96 | |
| Market cap as of 2026-08-06 | $2.5B | n/a | |
| P/E as of 2026-08-06 | 35.13 | n/a | |
| PEG as of 2026-08-06 | 4.77 | n/a | |
| Net margin as of 2026-08-06 | +11.4% | n/a | |
| Gross margin as of 2026-08-06 | +28.5% | n/a | |
| Operating margin as of 2026-08-06 | +15.3% | n/a | |
| ROE as of 2026-08-06 | +16.7% | n/a | |
| ROA as of 2026-08-06 | +10.8% | n/a | |
| Debt / equity as of 2026-08-06 | 0.25 | n/a | |
| Revenue growth (YoY) as of 2026-08-06 | +7.3% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +22.7% | n/a | |
| Beta as of 2026-08-06 | 1.07 | n/a | |
| 1-year return as of 2026-08-05 close | +33.8% | +15.4% | UFPT higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-05.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.